EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Peptide Nucleic Acid Origami for Cancer Diagnostics

Satheesh Natarajan, Everardo Cobos, Subhash C. Chauhan, Murali M. Yallapu

Biosensors · 2026-11-13 · 16 (11) · 652

DOI: 10.3390/bios16110652 ↗

At a glance

Journal article in Biosensors, published online on 2026-11-13. Written by Satheesh Natarajan and 3 co-authors. The full text is freely available (open access, CC BY 4.0). Funded by: National Institutes of Health, Cancer Prevention and Research Institute of Texas.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Liquid biopsy offers a minimally invasive approach to cancer detection and monitoring, but the analysis of rare, fragmented tumor-derived nucleic acids remains challenging because of their low abundance and interference from wild-type sequences. Peptide nucleic acids (PNAs), with their high-affinity hybridization, nuclease resistance, and single-base mismatch discrimination, provide a promising molecular recognition strategy for cancer diagnostics. This review critically examines PNA-based biosensors, PNA-containing nanostructures and emerging PNA-origami-inspired architectures for precision oncology. Unlike recent reviews that discuss only PNA chemistry, utilized in biosensing the individual biomarkers and DNA-origami technologies, this review uniquely focuses on PNA-origami nanoarchitectures for cancer diagnostics in nanoscale-level detection. It critically examines how the chemical modification, programmable nanoscale arrangement, and spatial arrangement of probes and reporters may enable multiplexed detection of cancer-associated mutations, DNA methylation signatures, gene-fusion junctions and circulating microRNAs in liquid-biopsy samples. Optical, plasmonic, colorimetric, electrochemical, and nanopore-based detection strategies are discussed alongside established PNA-clamping and biosensing approaches. Emphasis is placed on analytical performance, structural characterization, matrix compatibility, reproducibility, scalability, and benchmarking against digital PCR, next-generation sequencing, and CRISPR-based diagnostics. Key translation barriers include scalable production, reproducible assembly, matrix compatibility, analytical benchmarking and validation using patient-derived specimens. Currently, PNA origami should be considered a preclinical, origami-inspired design framework for spatially organized and multiplexed cancer biomarker detection, rather than a clinically implemented diagnostic technology.

Funding

  • National Institutes of Health
  • Cancer Prevention and Research Institute of Texas

Cite

APA

Natarajan, S., Cobos, E., Chauhan, S. C., & Yallapu, M. M. (2026). Peptide Nucleic Acid Origami for Cancer Diagnostics. Biosensors, 16(11), 652. https://doi.org/10.3390/bios16110652

Vancouver

Natarajan S, Cobos E, Chauhan SC, Yallapu MM. Peptide Nucleic Acid Origami for Cancer Diagnostics. Biosensors. 2026;16(11):652. doi:10.3390/bios16110652

BibTeX
@article{Natarajan2026,
  author = {Natarajan, Satheesh and Cobos, Everardo and Chauhan, Subhash C. and Yallapu, Murali M.},
  title = {Peptide Nucleic Acid Origami for Cancer Diagnostics},
  journal = {Biosensors},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {652},
  doi = {10.3390/bios16110652}
}
Start for free →